Engineering Compliance Audits

Overview

Facility and engineering systems form the foundation of reliable pharmaceutical and life-sciences operations. Weaknesses in layout, utilities, HVAC, maintenance, segregation, qualification, or contamination-control measures can directly affect product quality, patient safety, operational continuity, and regulatory compliance.

Mediature GxP Solutions Pvt. Ltd. (MGS) provides independent Engineering & Facility Compliance Audits for pharmaceutical, API, biopharmaceutical, medical-device, laboratory, and other regulated facilities.

Our audits evaluate whether facilities and engineering systems are appropriately designed, installed, operated, maintained, qualified, and documented in line with applicable GMP and technical expectations.

MGS combines engineering, validation, quality, and regulatory perspectives to identify gaps, assess associated risks, and provide practical recommendations for improvement.

Our Engineering & Facility Audit Services

Facility Layout & GMP Design Audits

Assessment of facility zoning, personnel and material flow, segregation, access control, cross-contamination risk, cleanroom classification, and overall GMP layout suitability.

HVAC & Cleanroom Audits

Evaluation of HVAC design, pressure differentials, temperature and humidity control, air-change rates, filtration, recovery, monitoring, qualification status, and cleanroom performance.

Utility System Audits

Assessment of critical utilities such as purified water, water for injection, clean steam, compressed air, process gases, chilled water, and other regulated utility systems.

Equipment & Engineering System Audits

Review of critical equipment, installation controls, maintenance, calibration, engineering documentation, spare-parts management, and lifecycle controls.

Maintenance System Audits

Assessment of preventive maintenance, breakdown maintenance, work-order systems, maintenance planning, equipment history, calibration interfaces, and maintenance documentation.

Qualification & Requalification Audits

Review of facility, utility, equipment, HVAC, and cleanroom qualification status, protocols, reports, deviations, acceptance criteria, and requalification strategy.

Contamination-Control Audits

Evaluation of facility controls related to segregation, cleaning, material movement, environmental control, pressure cascades, containment, and contamination prevention.

High-Potency & Containment Facility Audits

Assessment of facilities handling potent or hazardous materials, including containment strategy, segregation, engineering controls, personnel protection, and contamination-risk management.

Project & Expansion Compliance Audits

Review of new facilities, renovation projects, expansions, and engineering modifications to assess alignment with applicable GMP and project requirements.

Key Audit Focus Areas

Depending on the scope, MGS may assess:

• Facility layout and zoning
• Personnel flow
• Material flow
• Waste movement
• Segregation controls
• Cross-contamination prevention
• Cleanroom classification
• HVAC systems
• Pressure differentials
• Temperature and humidity controls
• Critical utilities
• Water systems
• Compressed air and gases
• Equipment installation
• Preventive maintenance
• Calibration
• Breakdown maintenance
• Engineering change control
• Qualification status
• Requalification
• Environmental monitoring interfaces
• Facility cleaning
• Pest-control interfaces
• Engineering documentation
• Equipment history records
• Spare-parts controls
• Utility monitoring
• Alarm management
• Containment systems
• Occupational exposure controls
• Energy efficiency considerations
• Business continuity and utility redundancy

Applicable Compliance Perspective

Depending on the facility type, product, process, and target market, audit criteria may consider applicable requirements and expectations associated with:

• US FDA
• EU GMP
• WHO GMP
• MHRA
• PIC/S
• TGA
• ANVISA
• Revised Schedule M
• Applicable cleanroom and engineering standards
• Relevant qualification and validation guidance
• Other national and international regulatory expectations

The final audit criteria are defined according to the client’s facility, process, product, and regulatory requirements.

Our Audit Process

• Define Scope

Understand the facility, manufacturing operations, utility systems, engineering controls, regulatory markets, and audit objectives.

• Prepare

Review available layouts, engineering drawings, qualification documents, maintenance records, utility data, and previous findings to prepare a focused audit plan.

• Conduct

Perform facility walkthroughs, engineering-system reviews, document assessment, personnel interviews, and evidence verification.

• Evaluate

Assess observations based on their potential impact on product quality, contamination control, equipment reliability, safety, and regulatory compliance.

• Report

Provide a structured audit report with observations, supporting evidence, risk significance, and practical recommendations.

• Follow Up

Where required, support remediation planning, engineering improvements, qualification strategy, CAPA review, and follow-up assessment.

Audit Deliverables

Depending on scope, MGS can provide:

• Audit agenda and assessment plan
• Facility compliance review
• Engineering-system assessment
• Utility-system assessment
• Qualification-status review
• Detailed audit report
• Observation summary
• Risk-based finding classification
• Remediation recommendations
• CAPA review support
• Follow-up audit support

Why Choose MGS for Engineering & Facility Compliance Audits

Engineering & GMP Expertise

MGS combines technical engineering knowledge with practical understanding of pharmaceutical GMP requirements.

Multidisciplinary Perspective

Our audits can integrate engineering, validation, quality, contamination-control, data-integrity, and regulatory considerations.

Practical Recommendations

Findings are structured to support realistic engineering and compliance improvements.

Facility Design Understanding

MGS brings experience in facility planning and design with consideration of applicable expectations associated with US FDA, MHRA, WHO GMP, TGA, ANVISA, Revised Schedule M, and other relevant requirements.

High-Potency & Containment Support

Specialized assessment capability for facilities requiring segregation, exposure control, containment, and enhanced contamination-prevention measures.

Lifecycle Approach

We assess facilities and systems across design, installation, qualification, operation, maintenance, modification, and requalification.

Who We Audit

MGS can support Engineering & Facility Compliance Audits for:

• Pharmaceutical manufacturing facilities
• API and intermediate plants
• Finished dosage form facilities
• Sterile manufacturing facilities
• Biopharmaceutical facilities
• Medical-device manufacturing sites
• Quality-control laboratories
• Warehouses and storage facilities
• Utility plants
• High-potency and containment facilities
• Greenfield and brownfield projects
• Existing facilities undergoing expansion or remediation